In addition, MYC hypomethylation was associated with advanced tumor stages (p = 0.033; OR = 6.602; 95% CI = 1.162–37.501), deeper tumor extension (p = 0.022; OR = 4.752; 95% CI = 1.257–17.965), and the presence of lymph node metastasis (p = 0.032; OR = 5.12; 95% CI = 1.149–22.814) (Table 1). Here, MYC is linked to neoplasm.